US FDA plant observations at Cipla cause 6-month delay in product launches: CEO
The biggest product under manufacture in the Pithampur facility is Advair which has a market size of $700 million
Source: moneycontrol.com
Cipla Results News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cipla Results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cipla Results Today - Breaking & Trending Today
Cipla reports 43% rise in PAT at Rs 1,130 crore in Q2; margins at 26%
The consolidated revenue from operations Cipla increased more than 14 per cent to Rs 6,589.22 crore in the second quarter of the ongoing fiscal.
Source: businesstoday.in
Cipla Q1 Results: Cipla Q1 Results: Cons PAT soars 45% YoY to Rs 996 crore, beats estimates
Consolidated operating profit, calculated as earnings before interest, taxes, depreciation, and amortization (EBITDA), grew by 31% on year to Rs 1,494.02 crore. Operating margin expanded a sharp 234 basis points to 23.6%.
Source: indiatimes.com
Cipla reports 45% jump in Q4 net profit; what should investors do now?
Cipla Q4: Motilal Oswal expect 12.3% earnings CAGR over FY23-25, led by 9%/11% sales CAGR in DF/NA segments and marginal improvement in profitability.
Source: moneycontrol.com
Q4 Results Cipla s Net Profit Rises By 40 YoY Consolidated Revenue At 5 739 Cr
Cipla Limited, the Indian pharmaceutical major headquartered in Mumbai has reported its earnings for the quarter that ended on 31st March 2023, the Indian pharma giant has registered a rise of 8.3 per cent in its consolidated revenue to be recorded at Rs 5,739 crores in the Quarter Four of Financial Year 2022(Q4FY23) up from Rs 5,260 crores in the corresponding quarter last year, , cipla q4 results, cipla ltd, Quaterly Result, q4 results, pharmaceutical, pharma news, Cipla q4, cipla results, cipla
Source: businessworld.in